Adrenergic alpha-2 Receptor Agonists/therapeutic use; Amphetamines/therapeutic use; Attention Deficit Disorder with Hyperactivity/drug therapy; Central Nervous System Stimulants/therapeutic use; Methylphenidate/therapeutic use; Adrenergic alpha-2 Receptor Agonists/administration & dosage; Adrenergic alpha-2 Receptor Agonists/adverse effects; Amphetamines/administration & dosage; Amphetamines/adverse effects; Attention Deficit Disorder with Hyperactivity/psychology; Behavior Therapy; Central Nervous System Stimulants/administration & dosage; Central Nervous System Stimulants/adverse effects; Child; Child, Preschool; Delayed-Action Preparations; Humans; Methylphenidate/administration & dosage; Methylphenidate/adverse effects; Transcutaneous Electric Nerve Stimulation

ADHD; Adderall; Adhansia; Adzenys; Aptensio; Biphentin; Concerta; Cotempla; Daytrana; Dexedrine; Dyanavel; Evekeo; Focalin; Foquest; Intuniv; Jornay PM; Kapvay; Methylin; Monarch eTNS; Mydayis; ProCentra; QuilliChew; Ritalin; Strattera; Vyvanse; Zenzedi; adverse effects; amphetamines; atomoxetine; clonidine; dexmethylphenidate; dextroamphetamine; dosage; drug interactions; efficacy; guanfacine; lactation; lisdexamfetamine; methylphenidate; pregnancy; safety; stimulants